Northern Financial Advisors Inc Has $1.32 Million Position in CVS Health Co. (NYSE:CVS)

Northern Financial Advisors Inc grew its holdings in CVS Health Co. (NYSE:CVS) by 22.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 16,738 shares of the pharmacy operator’s stock after buying an additional 3,113 shares during the quarter. CVS Health makes up 1.1% of Northern Financial Advisors Inc’s portfolio, making the stock its 26th largest position. Northern Financial Advisors Inc’s holdings in CVS Health were worth $1,322,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Concord Wealth Partners boosted its stake in shares of CVS Health by 3.4% in the 3rd quarter. Concord Wealth Partners now owns 5,229 shares of the pharmacy operator’s stock valued at $365,000 after purchasing an additional 170 shares during the last quarter. Everhart Financial Group Inc. bought a new position in shares of CVS Health in the 3rd quarter worth $253,000. Lindbrook Capital LLC increased its holdings in CVS Health by 7.2% in the third quarter. Lindbrook Capital LLC now owns 6,662 shares of the pharmacy operator’s stock valued at $465,000 after purchasing an additional 445 shares during the last quarter. Verdence Capital Advisors LLC boosted its holdings in CVS Health by 17.4% during the third quarter. Verdence Capital Advisors LLC now owns 14,668 shares of the pharmacy operator’s stock worth $1,024,000 after buying an additional 2,170 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of CVS Health by 3.3% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 414,042 shares of the pharmacy operator’s stock worth $28,908,000 after buying an additional 13,189 shares during the period. 80.66% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on CVS shares. StockNews.com cut shares of CVS Health from a “buy” rating to a “hold” rating in a research report on Thursday, February 15th. Wells Fargo & Company lowered their price target on CVS Health from $76.00 to $60.00 and set an “equal weight” rating for the company in a report on Tuesday. Leerink Partnrs cut CVS Health from an “outperform” rating to a “market perform” rating in a report on Wednesday, May 1st. SVB Leerink reiterated a “market perform” rating and set a $60.00 price objective (down from $87.00) on shares of CVS Health in a report on Wednesday, May 1st. Finally, TD Cowen downgraded shares of CVS Health from a “buy” rating to a “hold” rating and lowered their price objective for the company from $99.00 to $59.00 in a report on Tuesday. Nine investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $77.55.

Insider Activity

In other news, Director Edward J. Ludwig acquired 1,000 shares of the business’s stock in a transaction that occurred on Thursday, May 2nd. The stock was acquired at an average price of $53.88 per share, with a total value of $53,880.00. Following the completion of the transaction, the director now directly owns 21,630 shares of the company’s stock, valued at approximately $1,165,424.40. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the business’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the transaction, the executive vice president now owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Edward J. Ludwig purchased 1,000 shares of CVS Health stock in a transaction dated Thursday, May 2nd. The stock was bought at an average price of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the purchase, the director now owns 21,630 shares in the company, valued at approximately $1,165,424.40. The disclosure for this purchase can be found here. Corporate insiders own 0.24% of the company’s stock.

CVS Health Stock Performance

NYSE CVS traded down $0.55 on Wednesday, reaching $55.19. The stock had a trading volume of 5,899,692 shares, compared to its average volume of 11,804,591. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.61. The company has a market cap of $69.28 billion, a P/E ratio of 9.65, a price-to-earnings-growth ratio of 0.88 and a beta of 0.56. The firm has a fifty day moving average of $71.95 and a two-hundred day moving average of $73.09. CVS Health Co. has a 1-year low of $53.70 and a 1-year high of $83.25.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The business had revenue of $88.44 billion for the quarter, compared to the consensus estimate of $89.33 billion. During the same period in the prior year, the business posted $2.20 earnings per share. CVS Health’s revenue was up 3.7% compared to the same quarter last year. On average, equities research analysts anticipate that CVS Health Co. will post 7.03 EPS for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd were issued a $0.665 dividend. The ex-dividend date was Friday, April 19th. This represents a $2.66 annualized dividend and a yield of 4.82%. CVS Health’s dividend payout ratio is presently 46.75%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.